Evidence map›Paper›PMID 39204442›Full record

ArticlePharmaceutics2024

The Development and Pre-Clinical Anti-Inflammatory Efficacy of a New Transdermal Ureasil-Polyether Hybrid Matrix Loaded with Flavonoid-Rich

Camila Beatriz Barros Araújo, José de Oliveira Alves Júnior, Mariana Rillo Sato, Kammila Martins Nicolau Costa, Jéssica Roberta Lima, Bolívar Ponciano Goulart de Lima Damasceno, Francisco José Batista de Lima Junior, Bruna Galdorfini Chiari Andréo, Vanda Lucia Dos Santos, João Augusto Oshiro-Junior

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Prunin: An Emerging Anticancer Flavonoid.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Camila Beatriz Barros AraújoPharmaceutical Sciences Postgraduate Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-600, Brazil.
José de Oliveira Alves JúniorDepartment of Pharmacy, Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-500, Brazil.ORCID 0000-0002-4593-1816
Mariana Rillo SatoPharmaceutical Sciences Postgraduate Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-600, Brazil.
Kammila Martins Nicolau CostaPostgraduate Program in Development and Technological Innovation in Medicines, Federal University of Paraíba, Campus I, Lot. Cidade Universitária, S/N, João Pessoa 58051-900, Brazil.
Jéssica Roberta LimaDepartment of Pharmacy, University of Araraquara (UNIARA), Rua Carlos Gomes, 1338-Centro Araraquara, São Paulo 14801-340, Brazil.
Bolívar Ponciano Goulart de Lima DamascenoPharmaceutical Sciences Postgraduate Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-600, Brazil.
Francisco José Batista de Lima JuniorDepartment of Pharmacy, Unifacisa University Center, Rua Manoel Cardoso Palhano, 124-152-Itararé, Campina Grande 58408-326, Brazil.
Bruna Galdorfini Chiari AndréoDepartment of Pharmacy, University of Araraquara (UNIARA), Rua Carlos Gomes, 1338-Centro Araraquara, São Paulo 14801-340, Brazil.
Vanda Lucia Dos SantosPharmaceutical Sciences Postgraduate Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-600, Brazil.
João Augusto Oshiro-JuniorPharmaceutical Sciences Postgraduate Center for Biological and Health Sciences, Paraiba State University, Av. Juvêncio Arruda, S/N, Campina Grande 58429-600, Brazil.ORCID 0000-0001-7247-1598

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to develop a novel ureasil-polyether transdermal hybrid matrix (U-PEO) loaded with

Indexed as

Annonaceae familynew therapeutic systemssol-gel processtransdermal anti-inflammatory therapyureasil–polyether

Identifiers

PMID39204442
PMCPMC11359889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.